The report features an extensive study on the extensive study of the current landscape and the likel..
The report features an extensive study on the extensive study of the current landscape and the likel..
The development of such biologics is inherently complex, and many drug developers are now seeking to..
Since the approval of the first antisense drug in 1998, oligonucleotides have paved their way into t..
Most of the deals reported in the public domain are licensing and commercialization agreements..
More than 78% of the therapies are being evaluated in early stages, either as monotherapies or in co..
The report features an extensive study of the current market landscape of companies offering manufac..
A detailed discussion on the need for regulatory review / oversight across different stages of the m..
Most of the deals reported in the public domain are licensing and commercialization agreements..
More than 78% of the therapies are being evaluated in early stages, either as monotherapies or in co..